These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31493765)

  • 1. Age-specific urinary metabolite signatures and functions in patients with major depressive disorder.
    Chen JJ; Xie J; Li WW; Bai SJ; Wang W; Zheng P; Xie P
    Aging (Albany NY); 2019 Sep; 11(17):6626-6637. PubMed ID: 31493765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential urinary metabolites related with the severity of major depressive disorder.
    Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
    Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.
    Zheng P; Chen JJ; Zhou CJ; Zeng L; Li KW; Sun L; Liu ML; Zhu D; Liang ZH; Xie P
    Transl Psychiatry; 2016 Nov; 6(11):e955. PubMed ID: 27845778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulations of amino acid metabolism and lipid metabolism in urine of children and adolescents with major depressive disorder: a case-control study.
    Jiang Y; Cai Y; Teng T; Wang X; Yin B; Li X; Yu Y; Liu X; Wang J; Wu H; He Y; Zhu ZJ; Zhou X
    Psychopharmacology (Berl); 2024 Aug; 241(8):1691-1703. PubMed ID: 38605232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
    Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
    J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of urinary metabolite biomarkers for major depressive disorder.
    Zheng P; Wang Y; Chen L; Yang D; Meng H; Zhou D; Zhong J; Lei Y; Melgiri ND; Xie P
    Mol Cell Proteomics; 2013 Jan; 12(1):207-14. PubMed ID: 23111923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating Medicated Patients Suffering from Major Depressive Disorder from Healthy Controls by Spot Urine Measurement of Monoamines and Steroid Hormones.
    Wijaya CS; Lee JJZ; Husain SF; Ho CSH; McIntyre RS; Tam WW; Ho RCM
    Int J Environ Res Public Health; 2018 Apr; 15(5):. PubMed ID: 29701669
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification and validation of argininosuccinate synthase as a candidate urinary biomarker for major depressive disorder.
    Wu D; Peng Y; Zhou J; Yang YT; Rao CL; Bai SJ; Zhou XY; Chen J; Liao L; Liang ZH; Yang DY; Xie P
    Clin Chim Acta; 2015 Dec; 451(Pt B):142-8. PubMed ID: 26394130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
    Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
    J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel urinary metabolite signature for diagnosing major depressive disorder.
    Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
    J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.
    Ding X; Yang S; Li W; Liu Y; Li Z; Zhang Y; Li L; Liu S
    PLoS One; 2014; 9(5):e97479. PubMed ID: 24870353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major depressive disorder is associated with changes in a cluster of serum and urine biomarkers.
    van Buel EM; Meddens MJM; Arnoldussen EA; van den Heuvel ER; Bohlmeijer WC; den Boer JA; Muller Kobold A; Boonman-de Winter LJM; van Rumpt D; Timmers LFJ; Veerman MFA; Kamphuis JS; Gladkevich AV; Schoevers RA; Luiten PGM; Eisel ULM; Bosker FJ; Klein HC
    J Psychosom Res; 2019 Oct; 125():109796. PubMed ID: 31470255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic biosignature differentiates melancholic depressive patients from healthy controls.
    Liu Y; Yieh L; Yang T; Drinkenburg W; Peeters P; Steckler T; Narayan VA; Wittenberg G; Ye J
    BMC Genomics; 2016 Aug; 17(1):669. PubMed ID: 27549765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary peptidomics identifies potential biomarkers for major depressive disorder.
    Wang Y; Chen J; Chen L; Zheng P; Xu HB; Lu J; Zhong J; Lei Y; Zhou C; Ma Q; Li Y; Xie P
    Psychiatry Res; 2014 Jun; 217(1-2):25-33. PubMed ID: 24661976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder.
    Du Y; Wei J; Zhang Z; Yang X; Wang M; Wang Y; Qi X; Zhao L; Tian Y; Guo W; Wang Q; Deng W; Li M; Lin D; Li T; Ma X
    Front Psychiatry; 2021; 12():644555. PubMed ID: 34646171
    [No Abstract]   [Full Text] [Related]  

  • 18. Purine metabolism is dysregulated in patients with major depressive disorder.
    Ali-Sisto T; Tolmunen T; Toffol E; Viinamäki H; Mäntyselkä P; Valkonen-Korhonen M; Honkalampi K; Ruusunen A; Velagapudi V; Lehto SM
    Psychoneuroendocrinology; 2016 Aug; 70():25-32. PubMed ID: 27153521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics-based discrimination of patients with remitted depression from healthy controls using
    Hung CI; Lin G; Chiang MH; Chiu CY
    Sci Rep; 2021 Aug; 11(1):15608. PubMed ID: 34341439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.